Expression of tenascin in lymphocytic autoimmune thyroiditis

Journal of Clinical Pathology

Volumn 50, Issue 10, 1997, Pages 863-866

  Back, Walter ^a,c   Heubner, Cornelia ^a   Winter, Johannes ^b   Bleyl, Uwe ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Surgery ^*

^c University Medicine Mannheim   (Germany)

Author keywords

Autoimmune disease; Extracellular matrix; Lymphocytic thyroiditis; Tenascin

Indexed keywords

TENASCIN;

ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOCYTOCHEMISTRY; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0030680174     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.10.863     Document Type: Article

References (20)

1. Aufderheide E, Ekblom P. Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial- mesenchymal interactions. J Cell Biol 1988;107:2341-9.
2. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Osakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986;47:131-9.
3. Tucker RP, ed. Hypotheses and current knowledge. Perspec Dev Neurobiol 1994;2:1-132.
4. Erickson HP. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993;5:869-76.
5. Götz B, Scholze A, Clement A, Joester A, Schütte K, Wigger F, et al. Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons. J Cell Biol 1996;132:681-99.
6. Chuong C, Chen H. Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am J Pathol 1991;138:427-40.
7. Riedl SE, Faissner A, Schlag P, Herbay A von, Koretz K, Möller P. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. Gastroenterology 1992;103:400-6.
8. Schalkwijk J, Steijlen PM, van Vlijmen-Willems IMJJ, Oosterling B, Mackie EJ, Verstraeten AA. Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 1991;139:1143-50.
9. Pearson CA, Pearson D Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. Tenascin: c-DNA cloning and induction by TGH-β. EMBO J 1988;7:2977-81.
10. Chilosi M, Lestani M, Benedetti A, Montagna L, Pedron S, Scarpa A, et al. Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues. Am J Pathol 1993;143:1348-55.
11. Liakka KA, Autio-Harmainen HI. Distribution of the extracellular matrix proteins tenascin, fibronectin, and vitronectin in fetal, infant, and adult human spleens. J Histochem Cytochem 1992;40:1203-10.
12. Soini Y, Alavaikko M, Lehto VP. Tenascin in reactive lymph nodes and in malignant lymphomas. Pathol Res Pract 1992; 188:1078-82.
13. Ruegg CR, Chiquet-Ehrismann R, Alkan SS. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci USA 1989;86:7437-41.
14. Schröder S, Arndt R, Weinland G, Schuppert F. Morphologie und Klinik der Immunthyreopathien. Pathologe 1996; 17:276-88.
15. Mitchell JD, Kirkham K, Machin D. Focal lymphocytic thyroiditis in Southampton. J Pathol 1984;144:269-73.
16. Williams ED, Doniach I. The post-mortem incidence of focal thyroiditis. J Pathol Bacteriol 1962;83:255-64.
17. Ginsberg J, Walfish PG. Postpartum transient thyrotoxicosis with painless thyroiditis. Lancet 1977;i:1125-7.
18. Rosai J. Thyroid gland in: Rosai J, ed. Ackerman's surgical pathology. Vol 1. St Louis: Mosby, 1989:391-447.
19. Andersson J, Abrams J, Bjork L, Funa K, Litton M, Agren K, Andersson U. Concomitant in vivo production of 19 different cytokines in human tonsils. Immunology 1994;83: 16-24.
20. Back W, Heubner C. Tenascinexpression im aktivierten lymphatischen Gewebe der Schilddrüse und des Gastrointestinaltrakts. Verh Dtsch Ges Pathol 1996;80:326.